Literature DB >> 25501465

Evaluation of pediatric VCUG at an academic children's hospital: is the radiographic scout image necessary?

Jason G Domina1, Ramon Sanchez, Indu R Meesa, Emmanuel Christodoulou.   

Abstract

BACKGROUND: There is heterogeneity in how pediatric voiding cystourethrography (VCUG) is performed. Some institutions, including our own, obtain a radiographic scout image prior to contrast agent instillation.
OBJECTIVE: To demonstrate that the radiographic scout image does not augment VCUG interpretation or contribute management-changing information but nonetheless carries a non-negligible effective dose.
MATERIALS AND METHODS: We evaluated 181 children who underwent VCUG in 2012, with an age breakdown of less than 1 year (56 children), 1-5 years (66 children), 6-10 years (43 children) and 11-18 years (16 children), with a mean age of 4.0 years. We investigated patient demographics, clinical indication for the examination, scout image findings and estimated effective radiation dose, as well as overall exam findings and impression.
RESULTS: No clinically significant or management-changing findings were present on scout images, and no radiopaque urinary tract calculi or concerning incidental finding was identified. Scout image estimated effective radiation dose averaged 0.09 mSv in children younger than 1 y, 0.09 mSv in children age 1-5, 0.13 mSv in children age 6-10 and 0.18 mSv in children age 11-18. Total fluoroscopy time per examination averaged 36.7 s (range 34.8-39.6 s for all age group averages). Evaluation of known or suspected vesicoureteral reflux (VUR) and urinary tract infection (UTI) were the most common clinical indications, stated in 40.9% and 37.0% of exams, respectively.
CONCLUSION: Although the estimated effective dose is low for VCUG radiographic scout images, this step did not augment VCUG interpretation or contribute management-changing information. This step should be omitted or substituted to further reduce dose in pediatric VCUG.

Entities:  

Mesh:

Year:  2014        PMID: 25501465     DOI: 10.1007/s00247-014-3241-4

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  13 in total

1.  The efficacy of digital fluoroscopic image capture in the evaluation of vesicoureteral reflux in children.

Authors:  Nancy R Fefferman; Amy S Sabach; Rafael Rivera; Sarah Milla; Lynne P Pinkney; Naomi A Strubel; James Babb
Journal:  Pediatr Radiol       Date:  2009-08-29

2.  Physician documentation of fluoroscopy time in voiding cystourethrography reports correlates with lower fluoroscopy times: a surrogate marker of patient radiation exposure.

Authors:  Stephen Darling; Marla Sammer; Teresa Chapman; Marguerite T Parisi
Journal:  AJR Am J Roentgenol       Date:  2011-06       Impact factor: 3.959

3.  Relationship between radiologist training level and fluoroscopy time for voiding cystourethrography.

Authors:  Ruth Lim; Ranish Deedar Ali Khawaja; Katherine Nimkin; Pallavi Sagar; Randheer Shailam; Michael S Gee; Sjirk J Westra
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

4.  Paediatric urological investigations--dose comparison between urology-related and CT irradiation.

Authors:  Mark Page; Cosmin Florescu; Lilian Johnstone; Daniel Habteslassie; Michael Ditchfield
Journal:  Pediatr Radiol       Date:  2013-02-05

5.  Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.

Authors:  Kenneth B Roberts
Journal:  Pediatrics       Date:  2011-08-28       Impact factor: 7.124

6.  ICRP publication 121: radiological protection in paediatric diagnostic and interventional radiology.

Authors:  P-L Khong; H Ringertz; V Donoghue; D Frush; M Rehani; K Appelgate; R Sanchez
Journal:  Ann ICRP       Date:  2013-04

7.  Pediatric radiation exposure and effective dose reduction during voiding cystourethrography.

Authors:  Valerie L Ward; Keith J Strauss; Carol E Barnewolt; David Zurakowski; Vaidehi Venkatakrishnan; Frederic H Fahey; Robert L Lebowitz; George A Taylor
Journal:  Radiology       Date:  2008-10-21       Impact factor: 11.105

8.  Results of a European survey on patient doses in paediatric radiology.

Authors:  K Smans; E Vaño; R Sanchez; F W Schultz; J Zoetelief; T Kiljunen; C Maccia; H Järvinen; R Bly; A Kosunen; K Faulkner; H Bosmans
Journal:  Radiat Prot Dosimetry       Date:  2008-02-29       Impact factor: 0.972

9.  Effective dose estimation for pediatric voiding cystourethrography using an anthropomorphic phantom set and metal oxide semiconductor field-effect transistor (MOSFET) technology.

Authors:  Ryan Lee; Karen E Thomas; Bairbre L Connolly; Michelle Falkiner; Christopher L Gordon
Journal:  Pediatr Radiol       Date:  2009-02-25

10.  Imaging trends and radiation exposure in pediatric inflammatory bowel disease at an academic children's hospital.

Authors:  Jason G Domina; Jonathan R Dillman; Jeremy Adler; Emmanuel Christodoulou; Shokoufeh Khalatbari; Adam L Dorfman; Peter J Strouse
Journal:  AJR Am J Roentgenol       Date:  2013-07       Impact factor: 3.959

View more
  4 in total

1.  Pre-procedural scout radiographs are unnecessary for routine pediatric fluoroscopic examinations.

Authors:  Sean G Creeden; Anil G Rao; Meryle J Eklund; Jeanne G Hill; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2016-11-17

2.  Radiation exposure contribution of the scout abdomen radiograph in common pediatric fluoroscopic procedures.

Authors:  Anil G Rao; Cephus E Simmons; Paul G Thacker; Heather Collins; E Russell Ritenour; Jeanne G Hill
Journal:  Pediatr Radiol       Date:  2016-03-30

Review 3.  The ABCs of Voiding Cystourethrography.

Authors:  Yu Jin Kim; Bum Sang Cho; Junghwan Lee; Hyeonmi Ryu; Honggwon Byun; Miran Yeon; Yeongtae Park; Changhoon Oh; Younghun Jeon
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-01-31

4.  Effect of using immobilization device in fluoroscopic study in pediatric patient: Focused on radiation dose reduction in voiding cystourethrogram.

Authors:  Hyun-Hae Cho; So Mi Lee; Sun Kyoung You
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.